SCHEMBL7973174

SCHEMBL7973174

CCc1ccc(Cn2nc(-c3ccccc3)c(OCc3ccc(OC)cc3)c2C(=O)Nc2cc(C#N)ccc2N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.42
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 2/20 0.41
HPGD P15428 1/20 0.41
AKR1C3 P42330 6/20 0.40
HDAC2 Q92769 2/20 0.39
RECQL P46063 1/20 0.39
LNPEP Q9UIQ6 2/20 0.38
MAPT P10636 2/20 0.38
POLB P06746 1/20 0.38
GPR6 P46095 1/20 0.38
SLC2A1 P11166 1/20 0.37
SLC2A3 P11169 1/20 0.37
SLC2A4 P14672 1/20 0.37
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10172719 0.97 HDAC1 (0.43) HDAC1KDM4EALDH1A1HSD17B10AKR1C3
SCHEMBL10140161 0.83 ACHE (0.40)
SCHEMBL10140278 0.75 SMN1; SMN2 (0.48) AKR1C3POLBMEN1HTTKMT2A
SCHEMBL10140272 0.74 MEN1 (0.48) AKR1C3MAPTMEN1HTTKMT2A
SCHEMBL7961501 0.74 ACHE (0.35) GPR6
SCHEMBL16258930 0.74 RAB9A (0.52) KDM4EAKR1C3MAPTMEN1KMT2A
SCHEMBL16258988 0.73 HDAC1 (0.47) HDAC1HDAC2
SCHEMBL16258974 0.73 RAB9A (0.43) KDM4EALDH1A1HPGDAKR1C3MAPT
SCHEMBL10172717 0.67 NPSR1 (0.39) HSD17B10MAPTGPR6MEN1KMT2A
SCHEMBL16258931 0.67 LRRK2 (0.42) HDAC1KDM4EALDH1A1HDAC2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009143039-A2 HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2009-11-26 WO disclosed